| View |
|
DRP-10724-01
|
Ibuprofen
|
Ibufen
|
400 mg
|
Film-Coated Tablet
|
-
|
Centurion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 February 2022
|
15 November 2026
|
| View |
|
DRP-10779-01
|
Aluminum Hydroxide + Magnesium Hydroxide
|
Zilgam
|
200 mg/ 200 mg
|
Chewable Tablet (Peppermint Flavor)
|
-
|
Centurion Laboratories Pvt. ltd.
|
India
|
CLIDP Conversion
|
16 February 2022
|
19 November 2026
|
| View |
|
DRP-10835-01
|
Iron
|
Ferricore
|
105.6 mg (equivalent to 325 mg Ferrous Sulfate)
|
Sugar Coated Tablet
|
-
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 March 2022
|
02 December 2026
|
| View |
DRP-10512-01_PI_01.pdf
|
DRP-10512-01
|
Febuxostat
|
Efuboric
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 January 2022
|
07 October 2026
|
| View |
|
DRP-12601-01
|
Febuxostat
|
Laboxtat 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
20 October 2021
|
14 September 2027
|
| View |
|
DRP-10763-02
|
Dutasteride + Tamsulosin hydrochloride
|
Ambdart
|
500 mcg
|
400 mcg
|
Alpha-adrenoreceptor Antagonists
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
26 January 2022
|
16 November 2026
|
| View |
|
DRP-10868-06
|
Ascorbic Acid + Zinc
|
Royceevit
|
533.40mg (equivalent to 600 mg Sodium Ascorbate) + 10 mg (equivalent to 27.45 mg Zinc Sulfate)
|
Capsule
|
VITAMIN/MINERAL
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
30 October 2025
|
| View |
|
DRP-2170-02
|
Azithromycin (as dihydrate)
|
Cozith-S
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
08 October 2021
|
14 May 2025
|
| View |
|
DRP-5316-02
|
Diphenhydramine
|
Cladryl
|
12.5mg/5mL
|
Syrup
|
Antihistamine
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
17 January 2024
|
16 February 2029
|
| View |
|
DRP-9078-04
|
Sitagliptin (as phosphate)
|
Gliptins
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 July 2022
|
31 October 2025
|
| View |
|
DRP-11295
|
Ambroxol Hydrochloride
|
None
|
30 mg
|
Tablet
|
-
|
Centurion Laboratories Pvt. Ltd
|
India
|
Initial
|
24 November 2021
|
24 November 2026
|
| View |
|
DRP-6432-03
|
Levetiracetam
|
Levecare
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Hetero Labs Limited (Unit III)
|
India
|
CLIDP Conversion
|
19 October 2022
|
30 November 2027
|
| View |
|
DRP-10868-13
|
Ascorbic Acid + Zinc
|
Roseceevit
|
533.40 mg (equivalent to 600mg Sodium Ascorbate) + 10 mg (equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
VITAMIN & MINERAL
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
19 October 2022
|
30 October 2025
|
| View |
|
DRP-8584-15
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
BLOKACID
|
40 mg/30 mg
|
Modified-Release Capsule
|
Proton Pump Inhibitor/Gastrokinetic
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
25 April 2022
|
18 December 2024
|
| View |
|
DRP-10512-06
|
Febuxostat
|
None
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 February 2022
|
07 October 2026
|
| View |
|
DRP-9079-05
|
Sitagliptin (as phosphate)
|
None
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 August 2022
|
31 October 2025
|
| View |
|
DRP-3204-10
|
Azithromycin
|
Cupid
|
500 mg
|
Film-Coated Tablet
|
Antibacterial
|
Akums Drugs & Pharmaceuticals Ltd
|
India
|
Renewal
|
03 April 2024
|
01 September 2029
|
| View |
|
HMRP-26-01
|
Vitex negundo L. (Lagundi Leaf)
|
Ragundi
|
300 mg/ 5 mL
|
Syrup (Orange Flavor)
|
Herbal Medicine (Anti-cough/Antiasthma)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
29 April 2022
|
10 April 2027
|
| View |
|
DRP-6758-16
|
Paracetamol + Vitamin B-Complex
|
Dolonerv Forte
|
500 mg/50 mg/100 mg/100 mcg
|
Film-coated tablet
|
Analgesic/ Antipyretic/ Vitamin
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
21 March 2024
|
18 February 2029
|
| View |
|
DRP-10929-14
|
Norepinephrine (As Bitartrate)
|
Norisan
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
29 July 2022
|
31 January 2027
|